Prof. Orla Hardiman BSc, MD, FRCPI, FTCD, MRIA
Orla Hardiman is Professor of Neurology and Academic Director of Trinity Biomedical Sciences Institute, Trinity College Dublin, and Director of the National ALS where she provides clinical are for over 80% of Irish patients with ALS, and patients with other rare neuromuscular conditions.
Her research team of over 30 individuals is based at Trinity College and at the Research Centre at Beaumont Hospital. Her interests include deep phenotyping, biomarker discovery and population genetics of ALS. She is Co- Chair of the European Network for Cure of ALS (ENCALS) and is Editor in Chief of the journal Amyotrophic Lateral Sclerosis and the Frontotemporal Degenerations.
She is the recipient of a number of international awards including the AAN Sheila Essey Award in ALS Research and the International ALS Alliance Forbes Norris Award. Her work in cognition, epidemiology and population genetics has shown population based differences in genetic susceptibility to ALS, and a previously unrecognized overlap between ALS and neuropsychiatric disease.
Current work focuses on the clinical and genetic overlap between ALS, frontotemporal dementia and related conditions, and on the development of novel biomarkers that underpin disease heterogeneityShe is the author of over 250 peer reviewed research articles. Her research is funded by Science Foundation Ireland, the Health Research Board, The American Centre for Disease Control, The American ALS Association, the British MND Association the Irish MND Association and Research Motor Neuron.